Gefitinib, sold under the brand name Iressa, is a medication used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through …

2024年12月11日 · Gefitinib is a cancer medication that interferes with the growth and spread of cancer cells in the body. Gefitinib is used to treat non-small cell lung cancer . Gefitinib is …

2015年9月13日 · Gefitinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have certain types of abnormal epidermal growth factor …

Gefitinib is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase that binds to the adenosine triphosphate (ATP)-binding site of the enzyme. EGFR is often shown to be …

Gefitinib is used to treat lung cancer. It works by slowing or stopping the growth of cancer cells. Gefitinib blocks a certain protein (an enzyme called tyrosine kinase).

Gefitinib is approved to treat: Non-small cell lung cancer (NSCLC) that has metastasized (spread to other parts of the body). It is used as first-line treatment in patients whose tumors have …

Gefitinib is used to treat non-small cell lung cancer that has spread to other parts of the body in people with certain types of tumors. Gefitinib is in a class of medications called kinase inhibitors.

Gefitinib showed significant advantages in being more effective, safer and more stable, and the associated biopharmaceutical problems are addressed by the application of nanotechnology. …

Gefitinib is a type of targeted cancer drug. You pronounce it as jeh-fit-ih-nib. It is also known as Iressa. It is a treatment for non small cell lung cancer (NSCLC) that has spread into the …

Gefitinib belongs to a group of targeted therapy drugs known as cancer growth inhibitors. It is used to treat non-small cell lung cancer (NSCLC) that has started to spread to: surrounding …